EPFL spin-off Lemna Bio has raised CHF 150,000 from Venture Kick to develop its physics-driven AI platform, which makes ...

Organised by the Luxury Venture Group (LVG), the ‘Luxury Innovation Awards’ is a global c ompetition for startups and emerging brands recognizing their innovation, creativity, ...

The SEF.Growth High Potential Label acts as a seal of quality for companies that have strong growth strategies and high potential for significant market impact. The label enhances startups' ...

The new presence in Luxembourg is an additional step to expand our international footprint. The CYSEC Lab focuses on research and development of cybersecurity solutions for critical infrastructures, ...

CustomSurg’s innovative digital platform, OrthoPlanner (picture above), has been cleared from the U.S. Food and Drug Administration (FDA) as a medical device product. The software tool empowers ...

Enerdrape is setting the pace in the US. The EPFL spin-off is working currently on the Millennium Parking Garages in Chicago, the largest downtown public underground parking system in North America, ...

Intrapreneurship teams Five teams from corporate organizations have also been selected to further advance their solutions. KUORI (HSG START Accelerator), SecondWave (CSEM), SmartHear (CSEM), HELIOW ...

The second tranche of the Series C round brings total funds raised to more than CHF 125 million. The proceeds will be used to progress with the Phase 3 trial of the lead product denovoSkin and to ...

In a second program, supported by a CHF 1.5 million Innosuisse grant, cellvie is developing a mitochondria-enabled gene delivery platform that leverages the organelle’s unique biodistribution and ...

Renens-headquartered SWISSto12 has acquired Ku band active electronically steered antenna (AESA) user terminal technology and assets from Hanwha Phasor and will combine them with its own products and ...

An exclusive visit to Campus Biotech, a dynamic life-sciences hub in the heart of Geneva, which brings research, scientific ingenuity and opportunities together. ⚠️ Please note that due to limited ...

Based in Allschwil, Idorsia is a biopharmaceutical company specializing in the discovery, development, and commercialization of innovative drugs, primarily in neuroscience, cardiovascular, and ...